Insulin resistance is related to silent cerebral infarction in patients with essential hypertension

被引:24
|
作者
Kamide, K [1 ]
Rakugi, H [1 ]
Nakano, N [1 ]
Ohishi, M [1 ]
Nakata, Y [1 ]
Takami, S [1 ]
Katsuya, T [1 ]
Higaki, J [1 ]
Ogihara, T [1 ]
机构
[1] OSAKA UNIV, SCH MED, DEPT GERIATR MED, SUITA, OSAKA 565, JAPAN
关键词
essential hypertension; insulin resistance; silent cerebral infarction; periventricular hyperlucency; carotid wall thickness;
D O I
10.1016/S0895-7061(97)00282-3
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Recently, hyperinsulinemia or insulin resistance has been suggested to be a risk factor for cardiovascular diseases. We evaluated the role of insulin resistance in the occurrence of silent cerebral infarction in 28 patients with essential hypertension (40 to 75 years, 157 +/- 4/89 +/- 2 mm Hg). Patients with diabetes mellitus or obesity (BMI greater than or equal to 30) were excluded. Insulin resistance was evaluated by means of constant glucose infusion rate (M value) during euglycemic-hyperinsulinemic glucose clamp test. Infarction was defined as a focal area with prolonged T1 and T2 relaxation times that was >5 mm in diameter on brain magnetic resonance imaging. The severity of periventricular hyperlucency was evaluated by the distribution of the high intensity area. The number of silent infarctions significantly correlated only with the M value (F = 7.58, R-2 = 0.23, P = .01) in multiple regression analysis using all variables: age, blood pressure, smoking history, lipid profile, levels of plasma glucose and insulin on fasting, and total amounts during 75-g OGTT, However, the severity of periventricular hyperlucency did not show a correlation with any factors. The occurrence of cerebral infarction was significantly correlated with thickening of the intima-media complex (IMC) of the common carotid artery on B-mode ultrasonography (F = 8.43, R-2 = 0.25, P < .01). In conclusion, insulin resistance and thickening of IMC show a close relationship with the occurrence of silent cerebral infarction. Therefore, it may be important to improve insulin resistance for prevention of cerebral infarction in essential hypertensives. (C) 1997 American Journal of Hypertension, Ltd.
引用
收藏
页码:1245 / 1249
页数:5
相关论文
共 50 条
  • [1] Prevalence of Insulin Resistance and Related Risk Factors for Cardiovascular Disease in Patients With Essential Hypertension
    Lima, Nereida K. C.
    Abbasi, Fahim
    Lamendola, Cindy
    Reaven, Gerald M.
    AMERICAN JOURNAL OF HYPERTENSION, 2009, 22 (01) : 106 - 111
  • [2] Circulating resistin levels are not related to insulin resistance in essential hypertension
    Furuhashi, M
    Ura, N
    Higashiura, K
    Murakami, H
    Shimamoto, K
    HYPERTENSION, 2002, 40 (03) : 386 - 386
  • [3] Insulin resistance in essential hypertension is related to plasma renin activity
    L Lind
    R Reneland
    P-E Andersson
    A Haenni
    H Lithell
    Journal of Human Hypertension, 1998, 12 : 379 - 382
  • [4] Insulin resistance in essential hypertension is related to plasma renin activity
    Lind, L
    Reneland, R
    Andersson, PE
    Haenni, A
    Lithell, H
    JOURNAL OF HUMAN HYPERTENSION, 1998, 12 (06) : 379 - 382
  • [5] Insulin resistance and cardiovascular complications in patients with essential hypertension
    Kamide, K
    Nagano, M
    Nakano, N
    Yo, Y
    Kobayashi, R
    Rakugi, H
    Higaki, J
    Ogihara, T
    AMERICAN JOURNAL OF HYPERTENSION, 1996, 9 (12) : 1165 - 1171
  • [6] Silent cerebral lesions on magnetic resonance imaging and spectroscopy in patients with essential hypertension
    Malkova, J
    Kraml, P
    Stenhova, H
    Hajek, M
    JOURNAL OF HYPERTENSION, 2002, 20 : S171 - S171
  • [7] Silent cerebral infarction in hemodialysis patients
    Nakatani, T
    Naganuma, T
    Uchida, J
    Masuda, C
    Wada, S
    Sugimura, T
    Sugimura, K
    AMERICAN JOURNAL OF NEPHROLOGY, 2003, 23 (02) : 86 - 90
  • [8] Insulin resistance and insulin pulsatility in essential hypertension
    Wiggam, MI
    Hunter, SJ
    Armstrong, VL
    Ennis, CN
    Sheridan, B
    Atkinson, AB
    Bell, PM
    JOURNAL OF HYPERTENSION, 2000, 18 (06) : 743 - 748
  • [9] Lercanidipine Effect on Polymorphonuclear Leukocyte-Related Inflammation and Insulin Resistance in Essential Hypertension Patients
    Raymond Farah
    Revital Shurtz-Swirski
    Rola Khamisy-Farah
    Cardiology and Therapy, 2012, 1 (1)
  • [10] Lercanidipine Effect on Polymorphonuclear Leukocyte-Related Inflammation and Insulin Resistance in Essential Hypertension Patients
    Farah, Raymond
    Shurtz-Swirski, Revital
    Khamisy-Farah, Rola
    CARDIOLOGY AND THERAPY, 2012, 1 (01)